Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.430
+0.060 (2.53%)
Oct 10, 2025, 2:40 PM EDT - Market open
Oramed Pharmaceuticals Revenue
Oramed Pharmaceuticals had revenue of $2.00M in the twelve months ending June 30, 2025.
Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
48.73
Revenue / Employee
$500,000
Employees
4
Market Cap
99.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | 1.34M | -1.36M | -50.43% |
Dec 31, 2022 | 2.70M | -9.00K | -0.33% |
Dec 31, 2021 | 2.71M | 9.00K | 0.33% |
Aug 31, 2021 | 2.70M | -9.00K | -0.33% |
Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ORMP News
- 5 months ago - Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - GlobeNewsWire
- 5 months ago - Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical - PRNewsWire
- 7 months ago - Oramed Pharmaceuticals Issues Letter to Shareholders - PRNewsWire
- 8 months ago - Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin - PRNewsWire
- 1 year ago - Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - PRNewsWire
- 1 year ago - Oramed Letter to Shareholders - PRNewsWire
- 1 year ago - Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock - PRNewsWire
- 2 years ago - Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company - PRNewsWire